赢时胜(300377) - 2019 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders of the listed company reached ¥44,715,095.63, an increase of 5.98% year-on-year[7] - Operating revenue for the reporting period was ¥189,382,637.83, reflecting a growth of 13.95% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥44,035,964.29, up by 4.57% year-on-year[7] - Basic earnings per share for the reporting period were ¥0.0602, representing a 5.99% increase compared to the same period last year[7] - The weighted average return on net assets was 1.59%, an increase of 0.08% compared to the previous year[7] - The company reported a net profit margin improvement, with undistributed profits increasing to CNY 450,472,811.47 from CNY 399,658,743.99, a growth of about 12.7%[29] - Net profit for the current period was ¥44,710,504.64, slightly down by 0.8% from ¥45,058,254.55 in the previous period[37] - Total comprehensive income for the current period was ¥44,710,504.64, compared to ¥45,058,254.55 in the previous period, indicating a decline of 0.8%[38] - Net profit for the period was ¥126,917,522.96, up from ¥122,438,082.47, indicating a growth of about 3.9% year-over-year[46] - Total comprehensive income for the period was ¥131,032,723.94, compared to ¥119,063,337.39, reflecting an increase of about 10.1% year-over-year[47] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,205,850,213.21, a decrease of 0.13% compared to the end of the previous year[7] - The company reported a total net asset attributable to shareholders of ¥2,769,295,917.58, an increase of 2.05% from the previous year[7] - Total liabilities decreased to CNY 313,594,269.09 from CNY 375,184,392.45, reflecting a decline of approximately 16.4%[28] - The total equity attributable to shareholders rose to CNY 2,769,295,917.58, compared to CNY 2,713,651,911.51, an increase of approximately 2.1%[29] - The company’s long-term investments in equity increased to CNY 658,844,411.77 from CNY 618,739,687.62, showing an increase of about 6.5%[27] - Total current assets amounted to CNY 1,142,205,664.41, compared to CNY 1,094,304,671.08, indicating a growth of approximately 4.4%[32] - The company has a total of ¥4,760,277.02 in advance receipts, indicating future revenue expectations[65] - The company has a total of ¥43,730,853.59 in taxes payable, reflecting its tax obligations[65] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥47,665,475.72, a decrease of 72.36%[7] - The total cash inflow from operating activities for the period was CNY 479,872,380.16, an increase of 45.3% compared to CNY 329,901,590.79 in the previous period[51] - The net cash flow from operating activities was CNY -47,665,475.72, an improvement from CNY -172,471,395.59 in the same period last year[53] - Cash inflow from investment activities amounted to CNY 597,419,070.59, up from CNY 465,133,947.74, marking a 28.4% increase[53] - The net cash flow from investment activities was CNY 224,923,314.61, a significant recovery from CNY -215,815,338.25 in the previous year[53] - Cash inflow from financing activities totaled CNY 280,000,000.00, compared to CNY 150,520,000.00 in the prior period, reflecting an increase of 86.1%[53] - The net cash flow from financing activities was CNY -166,765,411.60, a decline from CNY 34,624,332.05 in the previous year[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 55,749[11] - The largest shareholder, Tang Qiu, holds 21.87% of the shares, totaling 162,300,779 shares[11] Investments and R&D - Investment income surged by 530.11% to CNY 5,113,743.76, due to higher returns from financial product investments compared to the previous year[18] - The company plans to continue focusing on R&D to drive future growth, as indicated by the significant increase in R&D expenses[36] - Research and development expenses increased significantly to ¥212,434,508.76 from ¥167,260,750.61, reflecting a growth of approximately 27% year-over-year[45] - The company maintained a strong focus on R&D, with expenses constituting a significant portion of total costs, indicating a commitment to innovation and market expansion[45] Other Financial Metrics - The company incurred a tax expense of ¥5,067,077.75, slightly higher than ¥5,034,376.93 in the previous period[37] - The company reported an asset impairment loss of ¥17,913,360.12, which increased from ¥12,682,919.17 year-over-year[46] - Other income decreased to ¥14,505,835.00 from ¥19,713,131.56, a decline of approximately 26.3% year-over-year[45]